Clinical Trial Update: Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated additive effects of rosiglitazone and fenofibrate on lipid levels in hypertriglyceridemia; the study was terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Ahmad Slim | Conditions: Hypertriglyceridemia in Type 4 Hyperlipidemia, Non Diabetic Subjects With Normoglycemia | Phase 4 | Status: TERMINATED | Results posted: 2014-02-26